Amino acid surface modified bioglass: A candidate biomaterial for bone tissue engineering1

Bioglasses are solid materials consisted of sodium oxide, calcium oxide, silicon dioxide and phosphorus in various proportions and have used in bone tissue engineering. There have been ongoing efforts to improve the surface properties of bioglasses to increase biocompatibility and performance. The aim of the present study is to modify the bioglass surface with an amino acid mixture consisting of arginine, aspartic acid, phenylalanine, cysteine, histidine and lysine, to characterize the surface, and to evaluate the performance and biocompatibility in vitro and in vivo. The untreated bioglass, bioglass kept in simulated body fluid (SBF), and modified bioglass were used in further evaluation. After confirmation of the surface modification with FT-IR analyses and SEM analyses, MC3T3-E1 preosteoblasts adhesion on the surface was also revealed by SEM. The modified bioglass had significantly higher ALP activity in colorimetric measurement, rate of calcium accumulations in Alizarin red s staining, lower rate of cell death in Annexin-V/PI staining to determine apoptosis and necrosis. Having higher cell viability rate in MTT test and absence of genotoxicity in micronucleus test (OECD 487), the modified bioglass was further confirmed for biocompatibility in vitro. The results of the rat tibial defect model revealed that the all bioglass treatments had a significantly better bone healing score compared to the untreated negative control. However, the modified bioglass exhibited significantly better bone healing efforts especially during the first and the second months compared to the other bioglass treatment treatments. As a result, the amino acid surface modification of bioglasses improves the surface biocompatibility and osteogenic performance that makes the amino acid modified bioglass a better candidate for bone tissue engineering. Research Highlights: Bioglass surface modification with amino acids contributes to bioglass-tissue interaction with an improved cell attachment. Modified bioglass increases in vitro Alp activity and calcium accumulation, and also positively affects cell behavior by supporting cell adaptation. Bioglass exerts osteogenic potential in vivo especially during early bone healing.

Keyword: amino acid modification; biocompatibility; bioglass; bone tissue engineering

Көрүүлөр
1
04.09.2024 күндөн тартып
Жүктөлгөн
1
04.09.2024 күндөн тартып
Акыркы кирүү датасы
12 Eylül 2024 08:33
Google текшерүү
Басыңыз
Толук текст
Толук көрүнүш
Басылманын аты
(dc.title)
Amino acid surface modified bioglass: A candidate biomaterial for bone tissue engineering1
Автор/лор
(dc.contributor.yazarlar)
Yasin Özkabadayı, Mustafa Türk, Ali Kumandaş, Siyami Karahan
Басылманын түрү
(dc.type)
Makale
Тили
(dc.language)
İngilizce
Жарыяланган жылы
(dc.date.issued)
2024
Улуттук/Эл аралык
(dc.identifier.ulusaluluslararasi)
Uluslararası
Булагы
(dc.relation.journal)
Microscopy Research and Technique
Саны
(dc.identifier.issue)
Published online: 18 August 2024
ISSN/ISBN
(dc.identifier.issn)
ISSN: 1059-910X; Online ISSN: 1097-0029
Басмаканасы
(dc.publisher)
Wiley
Маалымат базалар
(dc.contributor.veritaban)
Web of Science Core Collection
Маалымат базалар
(dc.contributor.veritaban)
Wiley
Маалымат базалар
(dc.contributor.veritaban)
Scopus
Индекс түрү
(dc.identifier.index)
SCI Expanded
Индекс түрү
(dc.identifier.index)
Scopus
Импакт-фактору
(dc.identifier.etkifaktoru)
2 / 2023-WOS / Son 5 yıl: 2,2
Қысқаша
(dc.description.abstract)
Bioglasses are solid materials consisted of sodium oxide, calcium oxide, silicon dioxide and phosphorus in various proportions and have used in bone tissue engineering. There have been ongoing efforts to improve the surface properties of bioglasses to increase biocompatibility and performance. The aim of the present study is to modify the bioglass surface with an amino acid mixture consisting of arginine, aspartic acid, phenylalanine, cysteine, histidine and lysine, to characterize the surface, and to evaluate the performance and biocompatibility in vitro and in vivo. The untreated bioglass, bioglass kept in simulated body fluid (SBF), and modified bioglass were used in further evaluation. After confirmation of the surface modification with FT-IR analyses and SEM analyses, MC3T3-E1 preosteoblasts adhesion on the surface was also revealed by SEM. The modified bioglass had significantly higher ALP activity in colorimetric measurement, rate of calcium accumulations in Alizarin red s staining, lower rate of cell death in Annexin-V/PI staining to determine apoptosis and necrosis. Having higher cell viability rate in MTT test and absence of genotoxicity in micronucleus test (OECD 487), the modified bioglass was further confirmed for biocompatibility in vitro. The results of the rat tibial defect model revealed that the all bioglass treatments had a significantly better bone healing score compared to the untreated negative control. However, the modified bioglass exhibited significantly better bone healing efforts especially during the first and the second months compared to the other bioglass treatment treatments. As a result, the amino acid surface modification of bioglasses improves the surface biocompatibility and osteogenic performance that makes the amino acid modified bioglass a better candidate for bone tissue engineering. Research Highlights: Bioglass surface modification with amino acids contributes to bioglass-tissue interaction with an improved cell attachment. Modified bioglass increases in vitro Alp activity and calcium accumulation, and also positively affects cell behavior by supporting cell adaptation. Bioglass exerts osteogenic potential in vivo especially during early bone healing.
Қысқаша
(dc.description.abstract)
Keyword: amino acid modification; biocompatibility; bioglass; bone tissue engineering
URL
(dc.rights)
https://analyticalsciencejournals.onlinelibrary.wiley.com/doi/10.1002/jemt.24659
DOI
(dc.identifier.doi)
10.1002/jemt.24659
Факультет / Институт
(dc.identifier.fakulte)
Veteriner Fakültesi
Бөлүмү
(dc.identifier.bolum)
Veteriner
Мекемедеги автор(лор)
(dc.contributor.author)
Ali KUMANDAŞ
Каттоо №
(dc.identifier.kayitno)
BL808D91E3
Каттоо киргизүү датасы
(dc.date.available)
2024-09-04
Эскертме (Жарыяланган жылы)
(dc.identifier.notyayinyili)
WOS, Scopus Early Access: AUG 2024
Wos No
(dc.identifier.wos)
WOS:001292935800001
Предметтик рубрикатор
(dc.subject)
amino acid modification
Предметтик рубрикатор
(dc.subject)
biocompatibility
Предметтик рубрикатор
(dc.subject)
bioglass
Предметтик рубрикатор
(dc.subject)
bone tissue engineering
Анализдер
Nəşr Baxılması
Nəşr Baxılması
Байланышкан өлкөлөр
Байланышкан шаарлар
Биздин милдеттенмелер жана cookie саясаты ТР № 6698- жеке маалыматтарды коргоо мыйзамы менен камтылган.
Макул

creativecommons
Bu site altında yer alan tüm kaynaklar Creative Commons Alıntı-GayriTicari-Türetilemez 4.0 Uluslararası Lisansı ile lisanslanmıştır.
Platforms